Luz Saude | Hospital da Luz Lisboa - Centro de Investigacao Clinica

Lisbon 1500-650

0 studies enrolling now · 5 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Biochemically Recurrent Prostate Cancer, Cancer, Chronic Kidney Disease, Heart Failure, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed